A type 2/3 metabotropic glutamate receptor agonist (DCG-IV) reduces the frequency of mEPSCs and SPWs.
2015 · Figshare · 0 citations
https://doi.org/10.1371/journal.pone.0007761.g006
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1
Papers
0
Citations
0
h-index
0
i10-index
Casale Malcolm is an academic researcher. The author has contributed to research in topics: Nitric Oxide and Endothelin Effects & S100 Proteins and Annexins & Eicosanoids and Hypertension Pharmacology.
Click to start Chat